[1] Umapathy S,Dhiman RK,Grover S,et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Am J Gastroenterol,2014,109(7):1011-1019. [2] Romero-Gómez M,Montagnese S,Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol,2015,62(2):437-447. [3] 段钟平. 肝病营养问题再关注. 实用肝脏病杂志,2014,17(5):449-451. [4] 朱倩,李云,段睿,等. 血清前白蛋白水平对肝切除术后肝功能不全发生的影响. 中国普通外科杂志,2016,25(1):109-114. [5] 李勋,李永炬,麦显峰. 严重创伤患者肠内营养与肠外营养的效果比较. 广东医学,2015,36(2):247-249. [6] 沈哲,马良,章文华. 微生态制剂对肝性脑病患者肠道菌群及血氨的影响. 中华医院感染学杂志,2014,24(10):2505-2507. [7] 邢卉春. 肝性脑病诊断治疗专家共识. 中华实验和临床感染病杂志:电子版,2009,1(4):51-56. [8] 崔厚松. 针刺十三鬼穴对肝性脑病患者血氨、内毒素、肿瘤坏死因子α的影响. 北京中医药,2016,35(2):167-169. [9] 陈桂敏,张然. 左旋门冬氨酸鸟氨酸联合纳洛酮对肝性脑病患者血氨及神志的影响. 中国实用神经疾病杂志,2016,19(18):120-122. [10] Goh ET,Way MJ,Atkinson SR,et al. Thu-032-variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis. J Hepatol,2016,64(2):257-257. [11] 戴丐国,伍登海,连建安,等. 微生态制剂联合肠内营养治疗肝性脑病的研究. 中华流行病学杂志,2014,35(12):1392-1395. |